YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558)

Market Cap	8.78B
Revenue (ttm)	3.96B
Net Income (ttm)	513.69M
Shares Out	879.97M
EPS (ttm)	0.58
PE Ratio	17.10
Forward PE	5.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,478,000
Average Volume	3,948,009
Open	9.91
Previous Close	10.02
Day's Range	9.81 - 10.16
52-Week Range	7.92 - 13.30
Beta	0.11
RSI	53.75
Earnings Date	Mar 21, 2025

About HKG:1558

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, sells, and markets pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic, and other diseases in the People’s Republic of China. It manufactures and sells active pharmaceutical ingredients; researches and develops pharmaceutical products, and medical devices and drugs, as well as biotechnology; and provides marketing and medical consulting services. The company sells its products to hospitals and medical institutions through a network of...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 4,618
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1558

Financial Performance

In 2024, HKG:1558's revenue was 3.72 billion, a decrease of -40.84% compared to the previous year's 6.29 billion. Earnings were 482.71 million, a decrease of -75.78%.

Financial numbers in CNY